11-hydroxyandrostenedione has been researched along with Prostatic Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| du Toit, T; Gent, R; Swart, AC | 1 |
| Bloem, LM; Schloms, L; Storbeck, KH; Swart, AC | 1 |
| Bartsch, G; Graf, AH; Hartmann, H; Klocker, H; Schiller, CD; Schneider, MR | 1 |
1 review(s) available for 11-hydroxyandrostenedione and Prostatic Neoplasms
| Article | Year |
|---|---|
11β-hydroxyandrostenedione returns to the steroid arena: biosynthesis, metabolism and function.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Androstenedione; Dihydrotestosterone; Humans; Hydroxysteroid Dehydrogenases; Male; Prostatic Neoplasms; Steroid 11-beta-Hydroxylase | 2013 |
2 other study(ies) available for 11-hydroxyandrostenedione and Prostatic Neoplasms
| Article | Year |
|---|---|
11α-Hydroxyprogesterone, a potent 11β-hydroxysteroid dehydrogenase inhibitor, is metabolised by steroid-5α-reductase and cytochrome P450 17α-hydroxylase/17,20-lyase to produce C11α-derivatives of 21-deoxycortisol and 11-hydroxyandrostenedione in vitro.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; 11-beta-Hydroxysteroid Dehydrogenase Type 2; 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Aged; Androstenedione; Cell Line, Tumor; Cortodoxone; HEK293 Cells; Humans; Hydroxyprogesterones; Male; Prostatic Neoplasms; Steroid 17-alpha-Hydroxylase | 2019 |
Growth-stimulating effect of adrenal androgens on the R3327 Dunning prostatic carcinoma.
Topics: Adenocarcinoma; Androstenedione; Animals; Castration; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Male; Neoplasms, Hormone-Dependent; Prostate; Prostatic Neoplasms; Rats; Rats, Inbred Strains; Stimulation, Chemical | 1991 |